Chromogranin a detection in saliva of type 2 diabetes patients

Bosnian Journal of Basic Medical Sciences

Volumn 10, Issue 1, 2010, Pages 2-8

  Soell, Martine ^a,b   Feki, Ahmed ^c   Hannig, Matthias ^d   Sano, Hidehiko ^e   Plnget, Michel ^c   Selimović, Denis ^b,c  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b INSERM   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^d SAARLAND UNIVERSITY   (Germany)

^e HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Chromogranin A; Diabetes type 2; Innate immunity saliva

Indexed keywords

EID: 77949346581     PISSN: 15128601     EISSN: None     Source Type: Journal    
DOI: 10.17305/bjbms.2010.2725     Document Type: Article

References (48)

1. Wang Z. and Wang G. APD: the antimicrobial peptide database. Nucleic Acids. Res. 2004; 32 D590-D592
2. Hoffmann J.A., Kafatos F.C., Janeway C.A., Ezekowitz R.A. Phylogenetic perspectives in innate immunity. Science 1999; 284: 1313-1318.
3. Müller U., Vogel P., Alber G., Schaub G.A.The innate immune system of mammals and insects. Contrib. Microbiol. 2008;15:21-44.
4. Papayannopoulos V., Zychlinsky A. NETs: a new strategy for using old weapons. Trends Immunol. 2009 ;30(11):513-521
5. Leclerc V., Reichhart J.M. The immune response of Drosophila melanogaster. Immunol Rev. 2004;198:59-71.
6. Blaschko H., Comline R.S., Schneider F.H. et al. Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulation. Nature 1967; 215:58-59.
7. Hagn C Schmid K.W., Fischer-Colbrie R. and Winkler H. Chro-mogranin A, B and C in human adrenal medulla and endocrine tissues . Lab. Invest. 1986;55:405-411.
8. Nolan J.A., Trojanowski J.Q. and Hogue A.R. (1985) Neurons and neuroendocrine cells contain chromogranin: detection of the molecule in normal bovine tissues by immunochemical and immunohistochemical methods. J Histochem Cytochem 33:791-798.
9. Lugardon K., Raffner R., Goumon Y. Et al. Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chro-mogranin A. J. Biol. Chem. 2000; 275:10745-10753.
10. Deftos J.L. Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker. Endocr. Rev. 1991; 12:181-187.
11. Lassmann H., Weiler R., Fischer P. et al. Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesicles. Neuroscience 1992;46:1-8.
12. Nishimura M., Tomimoto H., Suenaga T. Synaptophysin and chromogranin A immunoreactivities of Lewy bodies in Parkinson's disease brains. Brain. Res. 1994; 634:339-344.
13. Briolat J., Wu S.D., Mahata S.K. New antimicrobial activity for the cathecholamine release-inhibitory peptide from chromogranin A. Cell. Mol. Life Sci. 2005; 62:377-385.
14. Metz-Boutigue M.H., Garcia-Sablone P., Hogue-Angeletti R., and Aunis D. Intracellular and extracellular processing of chromo-granin A : determination of clivage sites. Eur. J. Biochem. 1993; 217 :247-257.
15. Metz-Boutigue M.H., Goumon Y., Strub J.M., Lugardon K. and Aunis D. Antibacterial and antifungal activities of chromogra-nins and proenkephalin-A-derived peptides. Ann N.Y. Acad. Sci;992:168-178.
16. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002;415:389-395.
17. Diamond G., Beckloff N., Ryan L.K. Host defense peptides in the oral cavity and the lung: similarities and differences. J. Dent Res. 2008; 87(10):915-927
18. Kieffer A.E., Goumon Y., Ruh O. The N- and C-terminal fragments of ubiquitin are important for the antimicrobial activities. FASEB J. 2003;17(6):776-778
19. Dossier Epidémiologique du Diabete Traite - Caisse national de l'Assurance maladie - 7 juin 2007.
20. Bonaldi C., Romon I., Fagot-Compana A. Impact du vieillisse-ment de la population et de l'obésité sur l'évolution de la prévalence du diabète traité: situation en France métropolitaine à l'horizon 2016. Bull Epidémiol Hebdo 2006. Institut Roche de l'Obésité, Inserm, ObEpi 2003 - ANAES, Principes de dépistage du diabete de type 2, 2003.
21. Soell M., Hassan M., Miliauskaite A., Haïkel Y., Selimovic D. The oral cavity of elderly patients in diabetes. Diabetes Metab. 2007;33 Suppl 1:S10-8
22. Bangou-Bredent J., Szmidt-Adjide V., Kangambega-Nouvier P. et al. Cardiovascular risk factors associated with diabetes in an Indian community of Guadeloupe. A case control study. Diabetes Metab. 1999;25(5):393-398
23. Hanaire H., Lassmann-Vague V., Jeandidier N., Renard E., Tu-biana-Rufi N., Vambergue A., Raccah D., Pinget M., Guerci B. Treatment of diabetes mellitus using an external insulin pump: the state of the art. Diabetes Metab. 2008; 34 (4 Pt 2)401-423.
24. Galkowska H., Olszewski W.L., Wojewodzka U. Expression of natural antimicrobial peptide beta-defensin-2 and Langerhans cell accumulation in epidermis from human non-healing leg ulcers. Folia Histochem. Cytobiol. 2005;43(3):133-136.
25. 4A) is mediated by mitochondrial dysregulation. Bosn. J. Basic Med. Sci. 2008; 8(1):4-11.
26. Selimovic D., Hassan M., Haikel Y., Hengge U.R. Taxol-induced mitochondrial stress in melanoma cells is mediated by activation of c-Jun N-terminal kinase (JNK) and p38 pathways via uncoupling protein. Cell Signal. 2008;20(2): 311-322.
27. -1 and NF-kappaB-dependent activation. Cell Signal. 2007;19(2):301-311.
28. Navazesh M., Kumar S.K. Xerostomia prevalence, diagnosis, and management. Compend. Contin. Educ. Dent. 2009;30(6):326-8, 331-332
29. Kawada S., Fukusaki C., Ohtani M., Kobayashi K. Effects of hyperoxic inhalation on psychological stress-induced salivary biomarkers. Biomed Res. 2009;30(4):245-249.
30. Shigeyama G, Ansai T., Awano S.et al. Salivary levels of Cortisol and chromogranin A in patients with dry mouth compared with age-matched controls. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;106(6):833-839
31. Fujimoto S., Nomura M., Niki M. et al. Evaluation of stress reactions during upper gastrointestinal endoscopy in elderly patients: assessment of mental stress using chromogranin A. J. Med. Invest. 2007;54(1-2):140-145.
32. Yamakoshi T., Park S.B., Jang W.C., Kim K., Yamakoshi Y., Hirose H. Relationship between salivary Chromogranin-A and stress induced by simulated monotonous driving. Med. Biol. Eng. Comput. 2009;47(4):449-456.
33. Wagner J., Cik M., Marth E et al. Feasibility of testing three salivary stress biomarkers in relation to naturalistic traffic noise exposure. Int. J. Hyg. Environ. Health. 2009; in press
34. Iorgulescu G. Saliva between normal and pathological. Important factors in determining systemic and oral health. J. Med. Life. 2009;2(3):303-307
35. Sato F., Kanno T., Nagasawa S. Immunohistochemical localization of chromogranin a in the acinar cells of equine salivary glands contrasts with rodent glands. Cells Tissues Organs. 2002;172(1):29-36.
36. Sobke A.C., Selimovic D., Orlova V. et al. The extracellular adherence protein from Staphylococcus aureus abrogates angiogenic responses of endothelial cells by blocking Ras activation. FASEB J. 2006;20(l4):2621-2623
37. Godaly G., Bergsten G., Hang L. et al. Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection. J. Leu-koc. Biol. 2001; 69: 899-906.
38. Tjabringa G.S. Vos J.B., Olthuis D. et al. Host defense effector molecules in mucosal secretions. FEMS Immunol. Med. Micro-biol. 2005; 45: 151-158.
39. Bäckhed F., Hornef M. Toll-like receptor 4-mediated signaling by epithelial surfaces: necessity or threat? Microbes Infect. 2003; 5:951-959.
40. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 2003; 3: 710-720
41. Schonwetter B.S., Stolzenberg E.D., Zasloff M.A. Epithelial antibiotics induced at sites of inflammation. Science 1995; 267: 1645
42. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol 2003; 2: 335-376.
43. Cordell P.A., Kile B.T., Standeven K.F., Josefsson E.C., Pease R.J., Grant P.J. Association of coagulation factor XIII-A with Golgi proteins within monocyte-macrophages: implications for subcellular trafficking and secretion. Blood. 2010; in press
44. Schroder K., Zhou R., Tschopp J. The NLRP3 inflammasome: a sensor for metabolic danger? Science. 2010;327(5963):296-300
45. Venieratos P.D., Drossopoulou G.I., Kapodistria K.D., Tsilibary E.C., Kitsiou P.V. High glucose induces suppression of insulin signalling and apoptosis via upregulation of endogenous IL-1beta and suppressor of cytokine signalling-1 in mouse pancreatic beta cells. Cell Signal. 2010; in press
46. Zhou R., Tardivel A., Thorens B., Choi I., Tschopp J.Thioredoxin- interacting protein links oxidative stress to inflammasome activation. J. Nat Immunol. 2010;11(2):136-140.
47. Mandosi E., Fallarino M., Gatti A., Carnovale A., Rossetti M., Lococo E., Buchetti B., Filetti S., Lenti L., Morano S. Atorvastatin Downregulates Monocyte CD36 Expression, Nuclear NFkappaB and TNFalpha Levels in Type 2 Diabetes. J. Atheroscler. Thromb. 2010; in press
48. 2 in patients with coronary artery disease. Tissue Antigens. 2009;74(5):386-392.